共 475 条
[1]
Borcoman E(2019)Novel patterns of response under immunotherapy AnnOncol 30 385-396
[2]
Kanjanapan Y(2020)Health-related quality of life in cancer patients treated with immune checkpoint inhibitors: a systematic review on reporting of methods in randomized controlled trials PLoS ONE 15 3801-11
[3]
Champiat S(2020)A decade of immune-checkpoint inhibitors in cancer therapy Nat Commun 11 1-270
[4]
Faury S(2018)Immune checkpoint inhibitors: recent progress and potential biomarkers Exp Mol Med 50 265-251
[5]
Foucaud J(2005)Combining immunotherapy with chemotherapy to treat cancer Discov Med 5 237-1823
[6]
Robert C(2012)Combining immunotherapy and targeted therapies in cancer treatment Nat Rev Cancer 12 1813-7
[7]
Darvin P(2015)Combining immunotherapy and anticancer agents: the right path to achieve cancer cure? Ann Oncol 26 132-41
[8]
Toor SM(2016)RECIST 1. 1-Update and clarification: from the RECIST committee Eur J Cancer 62 336-2121
[9]
Sasidharan Nair V(2010)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2108-2301
[10]
Elkord E(2018)Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer N Engl J Med 379 2288-757